Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Core Laboratories Inc. /DE/ Director's Dealing 2024

Apr 2, 2024

32685_dirs_2024-04-02_4e0cd38e-628a-4e5b-9577-e5e993afc9e1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Core Laboratories Inc. /DE/ (CLB)
CIK: 0001958086
Period of Report: 2024-04-01

Reporting Person: Straughen Michael (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-04-01 Common Stock F 3017 $17.13 Disposed 19869 Direct
2024-04-01 Common Stock M 6419 Acquired 22886 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-04-01 Restricted Shares $0 A 9317 Acquired Common Stock (9317) Direct
2024-04-01 Restricted Shares $0 M 6419 Disposed Common Stock (6419) Direct

Footnotes

F1: The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2025, subject to the terms of issuance.

F2: The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2024.